首页
订购/客服:400-666-5481

Vericiguat

    
10mM in DMSO

Vericiguat

源叶(MedMol)
T93284 一键复制产品信息
1350653-20-1
C19H16F2N8O2
426.38
BAY1021189;VerquvoCarbamic acid,N-​[4,​6-​diamino-​2-​[5-​fluoro-​1-​[(2-​fluorophenyl)​methyl]​-​1H-​pyrazolo[3,​4-​b]​pyridin-​3-​yl]​-​5-​pyrimidinyl]​-​,methyl ester
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
T93284-1ml促销
10mM in DMSO

¥234.00 ¥210.00

1 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: 鸟苷酸环化酶调节剂;Guanylate Cyclase Modulators;;InformationVericiguat Vericiguat (BAY1021189, Verquvo) is a potent, orally available and soluble guanylate cyclase (sGC) stimulator.TargetssGCIn vitroThe stimulation of sGC by Vericiguat is examined with a recombinant CHO cell line overexpressing rat sGC. Vericiguat stimulates the sGC reporter cell line concentration dependently with an EC50 of 1005 ± 145 nM. In the presence of the NO donor S-nitroso-N-acetyl-D,L-penicillamine (SNAP) (30 and 100 nM), the EC50 value shifts to 39.0 ± 5.1 and 10.6 ± 1.7 nM, respectively. In the presence of ODQ, pretreatment of the sGC reporter cell line with 10 μM ODQ for 3 h results in a significantly reduced efficacy of Vericiguat, with an EC50 of 256 ± 40 nM being observed.In vivoVericiguat can maintain heart and kidney function in a model of hypertension-induced end-organ damage with substantially reduced overall mortality.Cell Research(from reference)Cell lines:CHO cells Concentrations:0.01 μM to 100 μM Incubation Time:6 min 
体内研究: Vericiguat(化合物 24)通过口服给药(3 mg/kg 和 10 mg/kg,每日一次,持续 21 天)在 L-NAME 处理的肾素转基因大鼠高血压性终末器官损伤模型中展现出显著的心脏和肾脏功能保护作用。与对照组相比,Vericiguat 治疗组的大鼠总体死亡率显著降低 。
保存条件: -80℃(运输条件:冰袋低温运输)
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.345 ml 11.727 ml 23.453 ml
5 mM 0.469 ml 2.345 ml 4.691 ml
10 mM 0.235 ml 1.173 ml 2.345 ml
50 mM 0.047 ml 0.235 ml 0.469 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×